Expression of p21waf1, c erbB 2, and p53 Genes in Node Negative Breast Carcinoma and Their Clinical Significance
10.3321/j.issn:1000-467X.2001.06.016
- VernacularTitle:淋巴结阴性乳腺癌p21waf1、c-erbB-2和p53蛋白表达及其临床意义
- Author:
Wei DU
1
;
Guang Can ZENG
;
Hua Tie RONG
;
Hui Jing HOU
Author Information
1. Sun Yat sen University of Medical Sciences
- From:Chinese Journal of Cancer
2001;20(6):631-634
- CountryChina
- Language:Chinese
-
Abstract:
Objective:The aim of this study was to determine the expression of p21waf1, c erbB 2, and p53 in node negative breast cancer in relation to the clinicopathological parameters and prognosis. Methods: Expression of p21waf1, c erbB 2 and p53 in 121 patients were determined by LSAB immunohistochemical method, and Kaplan Meier method and Cox proportional hazard model were used to analyze the relationship of their expressions with prognosis. Results: (1) The expression rate of p21waf1 was 48.8% , and was in connection with histological grade and ER positive. (2) The expression rate of p53 and c erbB 2 was 36.4% and 26.4% respectively. C erbB 2 positive expression was associated with histological grade. (3) the expression of p21waf1 was inversely correlated with that of p53 protein (P< 0.05). (4) the results of survival analysis with Kaplan Meier method showed that better disease free survival(DFS) in the patients with p21waf1 expression than those without, the negative c erbB 2 expression exhibited a significantly better prognosis than positive c erbB 2 expression (P< 0.01). Conclusions: There was a significant correlation between the expression of p21waf1, c erbB 2,and tumor grade; a p53 indenpent pathway can mainly induce the expression of p21waf1; p21waf1 expression was a good prognostic marker for the patients with node negative breast cancer; c erbB 2 positive expression was an independent prognostic marker.